Amgen Pulls High-Price Version of Repatha in Bid to Raise Sales

(Bloomberg) -- Amgen Inc. will pull its higher-priced version of its cholesterol drug Repatha from the market, an effort to boost sales of the drug by offering only a lower-priced version of the pr...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.